Showing results (341-350 of 443) with videos related to

Sort By:
Pageof 45
Neurosurgery|February 14, 2007
Intracerebral infusate distribution by convection-enhanced delivery in humans with malignant gliomas: descriptive effects of target anatomy and catheter positioningJohn H Sampson, Martin L Brady, Neil A Petry, et al.
BMC Cancer|May 9, 2015
Mesothelioma patient derived tumor xenografts with defined BAP1 mutations that mimic the molecular characteristics of human malignant mesotheliomaNeetu Kalra, Jingli Zhang, Anish Thomas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 8, 2005
Pretargeted radioimmunotherapy of mesothelin-expressing cancer using a tetravalent single-chain Fv-streptavidin fusion proteinNoriko Sato, Raffit Hassan, Donald B Axworthy, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 26, 2017
Therapeutically targeting glypican-2 via single-domain antibody-based chimeric antigen receptors and immunotoxins in neuroblastomaNan Li, Haiying Fu, Stephen M Hewitt, et al.
Tissue Engineering. Part C, Methods|August 3, 2010
Transwells with microstamped membranes produce micropatterned two-dimensional and three-dimensional co-culturesYu-Suke Torisawa, Bobak Mosadegh, Stephen P Cavnar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2007
A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responsesDaniel H Sterman, Adri Recio, Richard G Carroll, et al.
Scientific Reports|March 8, 2017
Specific CpG hyper-methylation leads to Ankrd26 gene down-regulation in white adipose tissue of a mouse model of diet-induced obesityGregory A Raciti, Rosa Spinelli, Antonella Desiderio, et al.
Blood|October 7, 2017
Phase 1 study of the anti-CD22 immunotoxin moxetumomab pasudotox for childhood acute lymphoblastic leukemiaAlan S Wayne, Nirali N Shah, Deepa Bhojwani, et al.
American Journal of Physiology. Renal Physiology|January 15, 2015
Podocyte injury-driven intracapillary plasminogen activator inhibitor type 1 accelerates podocyte loss via uPAR-mediated β1-integrin endocytosisNamiko Kobayashi, Toshiharu Ueno, Kumi Ohashi, et al.
Antibody Therapeutics|November 20, 2020
COVID-19 antibody therapeutics tracker: a global online database of antibody therapeutics for the prevention and treatment of COVID-19Lifei Yang, Weihan Liu, Xin Yu, et al.
Pageof 45